1998年10月1日 · Spinocerebellar ataxia type 1 (SCA1) is characterized by progressive cerebellar ataxia, dysarthria, and eventual deterioration of bulbar functions. Early in the disease, affected individuals may have gait disturbance, slurred speech, difficulty with balance, brisk deep tendon reflexes, hypermetric saccades, nystagmus, and mild dysphagia.

Spinocerebellar ataxia type 1 (SCA1) is a progressive movement disorder that typically begins in early adulthood (but can affect children and older adults as well). Early signs and symptoms includes problems with coordination and balance (ataxia), speech and swallowing difficulties, muscle stiffness, and weakness in the muscles that control eye ...

Spinocerebellar ataxia type 1 (SCA1) is a condition characterized by progressive problems with movement. Explore symptoms, inheritance, genetics of this condition.

2022年8月29日 · Spinocerebellar ataxia (SCA) comprises more than 40 types of similar inherited brain disorders. SCA affects your cerebellum, a part of your brain vital to physical movement. It causes problems with coordination and movement. There’s no cure, so treatment aims to relieve symptoms and improve function. What is spinocerebellar ataxia?

Spinocerebellar Ataxia type 1 (SCA1) is one specific type of Ataxia among a group of inherited diseases of the central nervous system. In SCA1, genetic defects lead to impairment of specific nerve fibers carrying messages to and from the brain resulting in …

2023年9月15日 · Spinocerebellar ataxia (SCA) is an inherited (autosomal dominant), progressive, neurodegenerative, and heterogeneous disease that mainly affects the cerebellum. SCA is a subset of hereditary cerebellar ataxia and is a rare disease.

SCA1, SCA2 (183090), and SCA3, or Machado-Joseph disease (109150), are considered to be forms of ADCA I. These 3 disorders are characterized at the molecular level by CAG repeat expansions on 6p24-p23, 12q24.1, and 14q32.1, respectively.

SCA1 is an autosomal dominant disease which means that individuals of either sex are as equally likely to inherit the gene and develop the disease. Each child of a person with SCA1 has a 50 percent chance of inheriting the SCA1 gene.

SCA1 therapeutics can be classified as genetic, pharmacological, and cell replacement therapies. These different therapeutic strategies target either the (mutant) ATXN1 RNA or the ataxin-1 protein, pathways that play an important role in downstream SCA1 disease mechanisms or which help restore cells that are lost due to SCA1 pathology.

2016年12月2日 · Spinocerebellar ataxia type 1 (SCA1) is characterized by progressive cerebellar ataxia, dysarthria, and eventual deterioration of bulbar functions. Early in the disease, affected individuals may have gait disturbance, slurred speech, difficulty with balance, brisk deep tendon reflexes, hypermetric saccades, nystagmus, and mild dysphagia.